Catalyst Wire Dossier Catalyst Wire Dossier

Human Immune Globulin

intravenous immunoglobulin (IVIG)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Immune Globulin, covering 2013-09-19 to 2013-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]

See pricing